CVC Capital Partners has held a final close on €4.6bn for its second longer-life offering CVC Strategic Opportunities II.
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development
Latour acquired a controlling stake in the refrigeration systems provider in 2015
GNB will be part of GamaLife, a consolidation platform launched by Apax to pursue a buy-and-build strategy